Guided Therapeutics Inc (GTHP)

[FROZENFLAME]

Guided Therapeutics, Inc. (OTCQB: GTHP), developer of the LuViva(R)Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care, today announced it has received an order for seven additional LuViva(R) Advanced Cervical Scans and 4,000 disposable Cervical Guides for Indonesia. The order follows a recent recommendation that LuViva be included as an alternative to the Pap test at the 22nd Annual Scientific Meeting of the Society of Obstetricians and Gynecologists of Indonesia. The order brings to 14 the number of LuVivas and almost 7,000 the number of disposable Cervical Guides sold to Indonesia.